The biochemistry — cobalt-centered corrin ring, two coenzyme forms
Cobalamin is unique among vitamins in containing a trace element at its core. The molecule is built around a corrin ring — a four-pyrrole macrocyclic structure resembling the heme porphyrin ring — with a cobalt atom coordinated at the center. The cobalt center carries varying upper ligands (cyano, hydroxo, adenosyl, methyl), defining the four common cobalamin forms: cyanocobalamin (the synthetic stable form in vitamin premixes), hydroxocobalamin (the veterinary injectable form), adenosylcobalamin (one of the two active coenzyme forms, used by methylmalonyl-CoA mutase), and methylcobalamin (the second active coenzyme form, used by methionine synthase). Per standard biochemistry references, cyanocobalamin is converted in canine tissues to the two active coenzyme forms through cellular processing.
The two active coenzyme forms catalyze biologically distinct reactions. Methylcobalamin works with methionine synthase to remethylate homocysteine to methionine, regenerating the methyl donor pool used in DNA methylation, neurotransmitter synthesis, and amino acid metabolism. Adenosylcobalamin works with methylmalonyl-CoA mutase to convert methylmalonyl-CoA to succinyl-CoA — an essential step in catabolism of branched-chain amino acids (valine, isoleucine, methionine threonine), odd-chain fatty acids, and propionate. The breadth of cobalamin-dependent reactions explains why cobalamin deficiency produces both hematologic abnormalities (megaloblastic anemia from impaired DNA synthesis in rapidly dividing precursor cells) and neurologic abnormalities (subacute combined degeneration of the spinal cord in severe human deficiency).
Cobalamin absorption — intrinsic factor and the ileal receptor
Dietary cobalamin absorption requires a multi-step pathway involving stomach acid, pancreatic enzymes, intrinsic factor, and ileal receptor-mediated uptake. (1) Stomach acid releases cobalamin from food-protein binding. (2) Cobalamin in the stomach binds salivary haptocorrin, a protective carrier in acidic gastric conditions. (3) Pancreatic enzymes in the duodenum degrade haptocorrin, releasing cobalamin to bind intrinsic factor, a glycoprotein secreted by gastric parietal cells in humans but by pancreatic acinar cells in dogs (a notable species difference per Batt 1989 J Small Anim Pract). (4) The cobalamin-intrinsic-factor complex transits to the ileum (distal small intestine), where it binds the cubilin-amnionless receptor complex on enterocyte brush borders and is taken up via receptor-mediated endocytosis. (5) Cobalamin is released into portal circulation bound to transcobalamin II for tissue delivery.
Disruption at any step impairs cobalamin absorption. Exocrine pancreatic insufficiency (EPI) compromises step 3 because the pancreas cannot produce sufficient digestive enzymes to degrade haptocorrin and release cobalamin for intrinsic factor binding — producing the EPI-associated low serum cobalamin per Ruaux 2005 (JAVMA). SIBO compromises step 4 because bacterial overgrowth consumes cobalamin in the small intestinal lumen. Chronic enteropathy with ileal involvement compromises step 4 directly by destroying the enterocyte receptor complex. These three GI conditions all produce low serum cobalamin via different absorptive pathways, and serum cobalamin testing is the diagnostic gateway to discriminating among them. See best dog food for sensitive stomachs for the chronic-enteropathy nutritional context.
ACVIM 2022 GI consensus — serum cobalamin as biomarker
Per ACVIM 2022 chronic enteropathies consensus, Berghoff 2013 (JVIM) chronic enteropathy biomarker review, and Suchodolski 2021 (Vet Clin North Am SAP) small animal GI biomarker review, serum cobalamin is the single most-used diagnostic biomarker in canine GI medicine. The clinical-decision framework is: dog presents with chronic diarrhea, weight loss, or both → serum cobalamin measurement → if low (typically below 285 ng/L on most commercial reference ranges) one of EPI, SIBO/dysbiosis, or chronic enteropathy with ileal dysfunction is on the differential list → further workup (TLI for EPI, fecal microbiota assessment for SIBO/dysbiosis, GI biopsy for chronic enteropathy) discriminates among them.
Low serum cobalamin is sensitive but not specific — all three GI conditions and others (severe chronic gastritis, intestinal lymphangiectasia, intestinal lymphoma) can produce the finding. The complementary biomarker folate (vitamin B9) is interpreted alongside cobalamin: low cobalamin + high folate suggests SIBO (because bacteria synthesize folate and absorb in the proximal small intestine while consuming cobalamin in the lumen); low cobalamin + low folate suggests EPI or chronic enteropathy. This two-vitamin pattern interpretation is the canonical canine GI biomarker workup per ACVIM 2022 and Suchodolski 2021. See our B. subtilis explainer, E. faecium SF68 explainer, and L. rhamnosus LGG explainer for the probiotic adjuncts relevant to SIBO and chronic enteropathy management.
AAFCO 2024 minimum and dietary sources
Per AAFCO 2024 Official Publication dog food nutrient profiles, the cobalamin minimum is 0.028 mg/kg dry matter (DM) for adult maintenance and growth/reproduction — equivalent to 28 mcg/kg DM. No maximum is specified, reflecting that canine cobalamin toxicity from dietary or supplemental sources is essentially non-existent. The substantial safety margin is one of the reasons high-dose oral cobalamin supplementation is well-tolerated in dogs with confirmed cobalamin deficiency.
Dietary cobalamin sources are exclusively animal-derived: meat (especially liver, kidney, and other organ meats), fish, eggs, and dairy. Plants do not synthesize cobalamin and contain none unless contaminated with bacteria (or fortified, as some vegan human foods are). Per AAFCO 2024 Official Publication ingredient definitions, cyanocobalamin is the dominant synthetic cobalamin form in pet food vitamin premixes — chosen for stability under pet-food processing and storage conditions. AAFCO-compliant complete dog foods uniformly meet the requirement through a combination of meat ingredients and targeted cyanocobalamin premix supplementation. Owners do not need to track dietary cobalamin separately; AAFCO-compliant formulations cover the requirement by default. Plant-based or vegetarian dog diets require explicit cyanocobalamin supplementation to meet the AAFCO minimum, a formulation consideration per AAVCN 2024 Veterinary Therapeutic Diets framework.
How KibbleIQ scores cobalamin
The KibbleIQ Dry Kibble Rubric treats cobalamin as a baseline AAFCO-compliance requirement. All AAFCO-compliant complete dog foods meet the 0.028 mg/kg DM minimum by default through a combination of meat-ingredient natural cobalamin content and cyanocobalamin premix supplementation. The rubric does not award additional credit for cobalamin presence above the AAFCO minimum because cobalamin is not a clinical-outcome-distinguishing nutrient at standard dietary ranges in healthy dogs.
The more clinically interesting dimension of canine cobalamin runs through veterinary diagnostics — serum cobalamin testing as the GI biomarker discussed above — not through pet food choice. Cobalamin is not a tracked-supplement nutrient in the way that EPA + DHA, glucosamine, or taurine are. The clinical-decision framework for owners is that dietary cobalamin status is uniformly met by AAFCO-compliant commercial feeding, and intentional cobalamin supplementation is appropriate only when veterinarian-confirmed low serum cobalamin demands it as part of a broader GI workup. See our niacin (B3) explainer, choline explainer, and biotin explainer for the broader B-vitamin family context. To check whether your dog’s food carries appropriate B-vitamin premix declarations, paste the ingredient list into the KibbleIQ analyzer.